Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SIOP PNET 3: Chemotherapy vs Radiotherapy for Childhood CNS PNET
NCT00003859Phase 3Completed
- Sponsor
- SIOP
- Start
- Apr 1992
- Modality
- DNA Intercalators/Alkylators, Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of carboplatin, vincristine, cyclophosphamide and etoposide in primitive neuroectodermal tumor (PNET) and medulloblastoma (2 arms), sponsored by SIOP. Primary endpoint: Event-Free Survival at 5 years. Started Apr 1992; status: completed.
02
Drugs
carboplatinvincristinecyclophosphamideetoposide
03
Conditions
primitive neuroectodermal tumor (PNET)medulloblastoma
Beyond the preview
Go deeper on NCT00003859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003859.